Selecta Biosciences (SELB) Misses Q3 EPS by 9c; Reports Cash and Cash Equivalents of $140.0M
Get Alerts SELB Hot Sheet
Join SI Premium – FREE
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Selecta Biosciences (NASDAQ: SELB) reported Q3 EPS of ($0.16), $0.09 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $24.4 million versus the consensus estimate of $12.19 million.
For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kohl's (KSS) Misses Q1 EPS by 61c, Lowers FY Guidance, Provided Update on Strategic Alternatives Process
- Vipshop Holdings (VIPS) Tops Q1 EPS by 2c
- TJX Cos. (TJX) Tops Q1 EPS by 8c, Revenue Misses, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!